The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
For the first time, Thompson shares his journey living with gastroesophageal reflux disease (GERD) and experience using VOQUEZNA, as par ...
Setting a New Benchmark in Precision and Efficiency for LNP Analysis SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 31, 2025 / Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is ...
Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for administration of the drug to patients.
The public offer comprises a fresh issue of face value of ₹2 each aggregating up to ₹350 crore and an offer for sale of ₹350 ...